| SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | NovaBay Pharmaceuticals, Inc. | 380,949 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-13 | Altium Capital Management LP | NovaBay Pharmaceuticals, Inc. | 67,457 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-06 | Hudson Bay Capital Management LP | NovaBay Pharmaceuticals, Inc. | 718,678 | 10.0% | EDGAR |
| SC 13G | 2023-02-14 | ARMISTICE CAPITAL, LLC | NovaBay Pharmaceuticals, Inc. | 191,826 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-10 | Hudson Bay Capital Management LP | NovaBay Pharmaceuticals, Inc. | 225,909 | 10.0% | EDGAR |
| SC 13G | 2022-02-04 | Hudson Bay Capital Management LP | NovaBay Pharmaceuticals, Inc. | 4,971,292 | 10.0% | EDGAR |
| SC 13D/A | 2020-08-24 | Fu Jian Ping | NovaBay Pharmaceuticals, Inc. | 4,000,000 | 9.6% | EDGAR |
| SC 13G/A | 2020-02-14 | ARMISTICE CAPITAL, LLC | NovaBay Pharmaceuticals, Inc. | 1,465,426 | 5.0% | EDGAR |
| SC 13G/A | 2020-01-23 | Empery Asset Management, LP | NovaBay Pharmaceuticals, Inc. | 1,293,487 | 4.4% | EDGAR |
| SC 13G | 2019-08-19 | ARMISTICE CAPITAL, LLC | NovaBay Pharmaceuticals, Inc. | 1,747,944 | 6.9% | EDGAR |
| SC 13G | 2019-08-15 | Empery Asset Management, LP | NovaBay Pharmaceuticals, Inc. | 1,293,847 | 5.2% | EDGAR |
| SC 13D/A | 2019-04-16 | Fu Jian Ping | NovaBay Pharmaceuticals, Inc. | 5,683,304 | 33.0% | EDGAR |
| SC 13D/A | 2019-04-16 | OP Financial Ltd | NovaBay Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13D | 2018-05-17 | OP Financial Ltd | NovaBay Pharmaceuticals, Inc. | 1,700,000 | 9.9% | EDGAR |
| SC 13D/A | 2017-01-13 | China Pioneer Pharma Holdings Ltd | NovaBay Pharmaceuticals, Inc. | 5,212,748 | 34.4% | EDGAR |
| SC 13D | 2016-09-16 | Fu Jian Ping | NovaBay Pharmaceuticals, Inc. | 3,983,304 | 32.3% | EDGAR |
| SC 13D/A | 2016-08-04 | Pioneer Pharma (Singapore) Pte. Ltd. | NovaBay Pharmaceuticals, Inc. | 5,212,748 | 40.9% | EDGAR |
| SC 13D | 2016-03-04 | Pioneer Pharma (Singapore) Pte. Ltd. | NovaBay Pharmaceuticals, Inc. | 1,286,044 | 24.8% | EDGAR |
| SC 13G/A | 2015-02-11 | Najafi Ramin | NovaBay Pharmaceuticals, Inc. | 4,198,656 | 8.0% | EDGAR |
| SC 13G/A | 2014-02-14 | Najafi Ramin | NovaBay Pharmaceuticals, Inc. | 3,942,226 | 8.6% | EDGAR |